Trial record 1 of 1 for:    NCT00976404
Previous Study | Return to List | Next Study

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (EraMune02)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Objectif Recherche Vaccins SIDA
Pfizer
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Robert L. Murphy, Northwestern University
ClinicalTrials.gov Identifier:
NCT00976404
First received: September 9, 2009
Last updated: June 29, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)